Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome

Autor: A V, Vanlander, P G, Jorens, J, Smet, B, De Paepe, W, Verbrugghe, G G, Van den Eynden, F, Meire, P, Pauwels, N, Van der Aa, S, Seneca, W, Lissens, J G, Okun, R, Van Coster

Publikováno v: Acta anaesthesiologica Scandinavica. 56(4)

Propofol is an anesthetic agent widely used for induction and maintenance of anesthesia, and sedation in children. Although generally considered as reliable and safe, administration of propofol can occasionally induce a potentially fatal complication

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1a0d026a5fd7044ce87ec7f499fc1f97
https://pubmed.ncbi.nlm.nih.gov/22260353

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Autor: Salgado R; Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium., Denkert C; Institute of Pathology, Charité -University Hospital, Berlin, Germany., Demaria S; Perlmutter Cancer Center, New York University Medical School, New York, USA., Sirtaine N; Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Klauschen F; Institute of Pathology, Charité -University Hospital, Berlin, Germany., Pruneri G; European Institute of Oncology (IEO) and University of Milan, Milan, Italy., Wienert S; Institute of Pathology, Charité -University Hospital, Berlin, Germany., Van den Eynden G; Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium., Baehner FL; Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA., Penault-Llorca F; Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Perez EA; Division of Haematology/Medical Oncology and., Thompson EA; Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville., Symmans WF; Department of Pathology, The UT M.D. Anderson Cancer Center, Boston., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston., Brock J; Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA., Criscitiello C; Istituto Europeo di Oncologia, Milan, Italy., Bailey H; Genomic Health, Inc., Redwood City, USA., Ignatiadis M; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels., Floris G; Department of Pathology, University Hospital Leuven, Leuven, Belgium., Sparano J; Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA., Kos Z; Laboratory Medicine Program, University Health Network, University of Toronto, Toronto., Nielsen T; Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada., Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven., Allison KH; Department of Pathology, Stanford University Medical Centre, Stanford., Reis-Filho JS; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA., Loibl S; German Breast Group, Neu-Isenburg, Germany., Sotiriou C; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels., Viale G; Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy., Badve S; Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA., Adams S; Perlmutter Cancer Center, New York University Medical School, New York, USA., Willard-Gallo K; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Loi S; Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia sherene.loi@petermac.org.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Feb; Vol. 26 (2), pp. 259-71. Date of Electronic Publication: 2014 Sep 11.

Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.

Autor: Sleeckx N; Laboratory of Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. Electronic address: nathalie.sleeckx@uantwerpen.be., Van Brantegem L; Department of Pathology, Bacteriology and Poultry Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium., Van den Eynden G; Department of Pathology and Cytology, GZA Hospitals, Oosterveldlaan 24, 2610 Wilrijk, Belgium., Fransen E; StatUa Center for Statistics, University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium., Casteleyn C; Laboratory of Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium., Van Cruchten S; Laboratory of Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium., Veldhuis Kroeze E; Viroscience Laboratory, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands., Van Ginneken C; Laboratory of Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.

Publikováno v: Journal of comparative pathology [J Comp Pathol] 2014 Feb-Apr; Vol. 150 (2-3), pp. 184-93. Date of Electronic Publication: 2013 Nov 11.

Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.

Autor: Sleeckx N; Applied Veterinary Morphology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium. nathalie.sleeckx@ua.ac.be, Van Brantegem L, Fransen E, Van den Eynden G, Casteleyn C, Veldhuis Kroeze E, Van Ginneken C

Publikováno v: Journal of comparative pathology [J Comp Pathol] 2013 May; Vol. 148 (4), pp. 307-17. Date of Electronic Publication: 2012 Nov 02.

A 61-year-old female patient with right-sided pleuritic chest pain and fatigue. Diagnosis: Inflammatory pseudotumour causing right pulmonary artery occlusion with subsequent infarction of the lung.

Autor: Messaoudi N; Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium., De Cocker J, Van den Eynden G, Janssens A, Salgado RA, Van Marck EA, Van Schil PE

Publikováno v: The European respiratory journal [Eur Respir J] 2009 May; Vol. 33 (5), pp. 1231-5.